Autophagy-induced mesenchymal stem cell-derived extracellular vesicles ameliorated renal fibrosis in an in vitro model

Introduction: Chronic and progressive damage to the kidney by inflammatory processes, may lead to an increase in the extracellular matrix production, a condition known as renal fibrosis. The current study aims to evaluate if the extracellular vesicles (EVs) derived from autophagic adipose-derived mesenchymal stem cells (ADMSCs) can reduce the inflammation and extracellular matrix accumulation in damaged kidney tissue.Methods: Autophagy was induced in ADMSCs using 2 mu M concentration curcumin and was confirmed by evaluating LC3B, ATG7, and Beclin1 using real-time polymerase chain reaction (PCR) and Western blot. An in vitro renal fibrotic model was established in HEK-293 cells exposed to H2O2 (0.8mM) for 24 and 72 hours. The fibrotic model was confirmed through evaluation of collagen I, transforming growth factor-beta 1 (TGF-(31), E-cadherin, and vimentin genes expression using real-time PCR, collagen I protein by ELISA. After induction of fibrosis for 24 and 72 hours, the HEK cells were treated with NEVs (non-autophagy EVs) (50 mu M) or AEVs (autophagy EVs) (50 mu M) at 48, 96, and 124 hours, and then the samples were collected at 72 and 148 hours. Expression of collagen I, TGF-(31, E-cadherin, and vimentin Genes was evaluated via RT-PCR, and protein levels of IL1, TNF-alpha, IL4, IL10 using ELISA.Results: Induction of autophagy using curcumin (2 mu M) for 24 hours significantly increased LC3B, Beclin1, and ATG7 in the ADMSCs. Upregulation in anti-fibrotic (E-cadherin) and anti-inflammatory (IL4, IL10) gene expression was significantly different in the fibrotic model treated by AEVs compared to NEVs. Also, the downregulation of fibrotic (TGF-(31, vimentin, collagen I) and pro-inflammatory (IL1, TNF alpha) gene expression was significantly different in AEVs compared with those treated by NEVs.Conclusion: Our findings suggest that AEVs can be considered as a therapeutic modality for renal fibrosis in the future.

Automated summary

This study aimed to evaluate whether extracellular vesicles (EVs) derived from autophagic adipose-derived mesenchymal stem cells (ADMSCs) can reduce inflammation and extracellular matrix accumulation in damaged kidney tissue. The results showed that treatment with AEVs significantly reduced the expression of fibrotic and pro-inflammatory genes compared to NEVs, suggesting that AEVs could be a potential therapeutic modality for renal fibrosis.